The regulation of neovascularization of matrix metalloproteinases and their inhibitors

Stem Cells
Marsha A Moses

Abstract

The process of new capillary formation from preexisting vessels, angiogenesis, is a complex physiological event which is strictly controlled, occurring only very rarely under normal conditions. In contrast, there are a number of serious diseases, among them solid tumor growth, rheumatoid arthritis and several eye diseases, which are characterized by unrestricted new capillary growth and which are described as "angiogenic diseases." One of the key events required for successful angiogenesis is extracellular proteolysis. Increased attention has been focused on matrix metalloproteinase (MMP) family of enzymes whose activity is a rate-limiting step in extracellular matrix remodeling. This review will present the accumulating body of evidence, from a number of laboratories, which documents the important role of MMP activity in the regulation of angiogenesis. Taken together, these data suggest that one strategy for controlling the deregulated angiogenesis characteristic of these serious angiogenic diseases may be one which is operative at the level of the control of MMP activity.

References

Sep 28, 1979·Science·V Muthukkaruppan, R Auerbach
Feb 1, 1975·The Journal of Experimental Medicine·H Brem, J Folkman
Jul 1, 1991·Bio/technology·M A Moses, R Langer
Jun 1, 1990·Biochimica Et Biophysica Acta·C H Blood, B R Zetter
Dec 2, 1990·Cell Differentiation and Development : the Official Journal of the International Society of Developmental Biologists·M S Pepper, R Montesano
Nov 1, 1991·Journal of Cellular Biochemistry·M A Moses, R Langer
Jan 1, 1991·Pharmacology & Therapeutics·W Risau
Feb 1, 1991·In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association·K PaigeS J Braunhut
Oct 1, 1991·The Journal of Investigative Dermatology·B BertauxL Dubertret
Apr 1, 1990·Trends in Genetics : TIG·L M Matrisian
Jun 1, 1990·The Biochemical Journal·R A WilliamsonR B Freedman
Jan 23, 1987·Science·J Folkman, M Klagsbrun
Jan 1, 1987·Nouvelle Revue Française D'hématologie·A Camez, G Tobelem
Aug 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M Fràter-SchröderP Böhlen
Nov 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·G I GoldbergC S He
Mar 1, 1985·Collagen and Related Research·H G WelgusG P Stricklin
Apr 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·D F CarmichaelG P Stricklin
Feb 1, 1974·Journal of the National Cancer Institute·M A GimbroneJ Folkman
Jul 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·R LangerJ Folkman
Dec 1, 1982·The Journal of Cell Biology·J L GrossD B Rifkin
Apr 1, 1984·British Journal of Cancer·B Hobson, J Denekamp
Apr 1, 1994·Developmental Biology·C FisherM A Mitchell
Jul 1, 1994·Journal of Cellular Physiology·M D JohnsonP J Polverini

❮ Previous
Next ❯

Citations

Nov 19, 2008·Archives of Otolaryngology--head & Neck Surgery·J Robert NewmanEben L Rosenthal
Jun 22, 2000·Biochemical and Biophysical Research Communications·H Wang, J A Keiser
May 12, 2001·Pathology Oncology Research : POR·A John, G Tuszynski
Apr 30, 2013·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Panagiotis DadoukisEleni Papakonstantinou
Dec 5, 2008·Molecular and Cellular Biochemistry·R I VijiP R Sudhakaran
Oct 10, 2007·Veterinary Research Communications·L A RibeiroM Forni
Jun 12, 2012·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Xiaoxi ZhouYang Cao
Dec 21, 2000·Current Oncology Reports·I Wu, M A Moses
Mar 24, 2004·Critical Reviews in Oncology/hematology·Georges BellonArnaud Robinet
Oct 25, 2003·Progress in Retinal and Eye Research·Arup Das, Paul G McGuire
Jun 8, 2002·Survey of Ophthalmology·Tina T L WongPeng T Khaw
Nov 7, 2002·International Journal of Radiation Oncology, Biology, Physics·Peter C BrooksSilvia C Formenti
Apr 28, 2000·The International Journal of Biochemistry & Cell Biology·M NguyenC J Jackson
Oct 14, 2003·International Immunopharmacology·M B SantucciM Fraziano
Aug 27, 2011·Journal of Medicinal Chemistry·Major GooyitMayland Chang
Apr 20, 2004·Current Opinion in Nephrology and Hypertension·Vera Eremina, Susan E Quaggin
Mar 31, 2009·Journal of Pediatric Gastroenterology and Nutrition·Michael A ManfrediMarsha A Moses
Apr 6, 1999·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·A Lochter, M J Bissell
Jun 6, 2000·The British Journal of Ophthalmology·C S SethiN H Chong
Nov 14, 2002·Canadian Journal of Applied Physiology = Revue Canadienne De Physiologie Appliquée·Tara L Haas
May 7, 2010·Journal of Oncology·Fernando Nussenbaum, Ira M Herman
Oct 24, 2002·The Journal of Clinical Investigation·Sujin LeeBarry T Rouse
Feb 27, 2003·Clinical Evidence·Nigel Barker
Aug 19, 2011·Experimental & Molecular Medicine·Hee Seok YangByung Soo Kim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.